Affinity Asset Advisors, LLC

CIK: 0001773195Latest portfolio: $1.8B · Q4 2025

Holdings

92

Total Value

$1.8B

New Positions

24

Closed Positions

26

#StockSharesValue% PortfolioChangeType
1
XBISPDR SERIES TRUST
1,500,000$182.9M10.42%NEWPut
2
APGEAPOGEE THERAPEUTICS INC
1,234,926$93.2M5.31%+62K
3
IM8NINSMED INC
450,000$78.3M4.46%NEW
4
ABVXABIVAX SA
505,000$68.1M3.88%+145K
5
IBBISHARES TR
400,000$67.5M3.85%NEWCall
6
VTYXVENTYX BIOSCIENCES INC
6,484,558$58.6M3.34%+2.6M
7
XENEXENON PHARMACEUTICALS INC
1,250,000$56.0M3.19%-150,000
8
PRAXPRAXIS PRECISION MEDICINES I
185,000$54.5M3.11%NEW
9
CYTKCYTOKINETICS INC
800,000$50.8M2.90%+450K
10
AMGNAMGEN INC
145,000$47.5M2.70%NEWCall
11
SYRESPYRE THERAPEUTICS INC
1,432,591$46.9M2.67%+13K
12
WVEWAVE LIFE SCIENCES LTD
2,700,000$45.9M2.62%+600K
13
TEVATEVA PHARMACEUTICAL INDS LTD
1,400,000$43.7M2.49%
14
XLVSELECT SECTOR SPDR TR
250,000$38.7M2.21%NEWCall
15
ROIVROIVANT SCIENCES LTD
1,700,000$36.9M2.10%+900K
16
ACLXARCELLX INC
523,725$34.1M1.95%+24K
17
NUVLNUVALENT INC
322,633$32.5M1.85%-61,784
18
LXEOLEXEO THERAPEUTICS INC
3,200,000$31.8M1.81%-670,527
19
ALKSALKERMES PLC
1,000,000$28.0M1.59%-250,000
20
FBRXFORTE BIOSCIENCES INC
1,011,890$27.6M1.57%NEWCall
21
TRVITREVI THERAPEUTICS INC
2,150,172$26.9M1.53%-649,828
22
MLYSMINERALYS THERAPEUTICS INC
730,000$26.5M1.51%-20,000
23
BBIOBRIDGEBIO PHARMA INC
320,000$24.5M1.39%+255K
24
ORKAORUKA THERAPEUTICS INC
802,342$24.3M1.39%-156,838
25
TERNTERNS PHARMACEUTICALS INC
550,000$22.2M1.27%NEW

Quarterly Changes

New Positions

Closed Positions

Increased Positions

NameSharesChange
OVID7.2M+4.5M
VTYX6.5M+2.6M
YB4P2.8M+1.3M
OMER 9.5 06/15/296.5M+1.0M
JBIO715K+650K
WVE2.7M+600K
ZURA1.8M+539K
CYTK800K+450K
I9DN522K+310K
TSHA3.3M+300K

Decreased Positions

NameSharesChange
PRQR2.5M-1145722
LXEO3.2M-670527
TRVI2.2M-649828
ERAS3.9M-385787
ALKS1.0M-250000
TVTX300K-200000
ORKA802K-156838
OBIO573K-154468
XENE1.3M-150000
DNTH115K-147100

Sector Breakdown

HealthcareNaN% ($InfinityT)
Unknown0.0% ($7.831819383168671e+32T)
Financial Services0.0% ($18289567508.4T)
Technology0.0% ($1K)

Filing History

QuarterFiling DatePortfolio ValueHoldings
Q4 2025Feb 13, 2026$1.8B95
Q3 2025Nov 13, 2025$1.1T96
Q2 2025Aug 13, 2025$732.2B0
Q1 2025May 14, 2025$1.0T98
Q4 2024Feb 13, 2025$746.0B85
Q3 2024Nov 13, 2024$732.8T86
Q2 2024Aug 14, 2024$867.5T98
Q1 2024May 14, 2024$807.8T95
Q4 2023Feb 13, 2024$547.5T82
Q3 2023Nov 14, 2023$355.5T81
Q2 2023Aug 14, 2023$286.8T71
Q1 2023May 15, 2023$303.0T74
Q4 2022Feb 13, 2023$255.0T63
Q3 2022Nov 14, 2022$358.3B64
Q2 2022Aug 12, 2022$237.2B54
Q1 2022May 13, 2022$625.0B59
Q4 2021Feb 11, 2022$275.4B55
Q3 2021Nov 12, 2021$396.0B73
Q2 2021Aug 13, 2021$279.3B69
Q1 2021May 14, 2021$294.5B72
Q4 2020Feb 12, 2021$188.7B62

Fund Information

CIK0001773195
Most Recent FilingFeb 13, 2026
Number of Filings21

Affinity Asset Advisors, LLC is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $1.8B across 92 holdings. The largest position is SPDR SERIES TRUST (XBI), representing 10.4% of the portfolio. Compared to the previous quarter, the fund opened 30 new positions and closed 31 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.